![Stuart Edelstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Stuart Edelstein
Entité | Type d'entité | Industrie | |
---|---|---|---|
Scipio Bioscience SAS
![]() Scipio Bioscience SAS Miscellaneous Commercial ServicesCommercial Services Scipio Bioscience SAS operates as a biotechnology company. It provides a novel sample preparation solution for single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular transcriptomics. The company was founded by Pierre Walrafen and Stuart Edelstein on August 2, 2017 and is headquartered in Paris, France.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Stuart Edelstein via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Monatomics Technology SAS | Director/Board Member | ||
IIF Management Co. LLC
![]() IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California. | Investment Managers | Private Equity Investor | |
Pictor Labs, Inc.
![]() Pictor Labs, Inc. Information Technology ServicesTechnology Services Pictor Labs, Inc. engages in technology industry. The company is headquartered in Los Angeles, CA. | Information Technology Services | Director/Board Member | |
NanoSyrinx Ltd
![]() NanoSyrinx Ltd Miscellaneous Commercial ServicesCommercial Services NanoSyrinx Ltd is a discovery stage biotechnology company that is based in the UK. The British company is focused on developing protein nanosyringes as a new way to deliver protein and peptide biologic drugs intracellularly. The company uses synthetic biology approaches to achieve this goal. The company was founded by Joseph Healey, Alexia Hapeshi, and Nicholas Waterfield, with Joseph Healey serving as the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Merck Ventures BV
![]() Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor | |
Seventure Partners SA
![]() Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Private Equity Analyst | |
Ecole Polytechnique | College/University | Undergraduate Degree | |
Q Squared Solutions (Quest) Ltd.
![]() Q Squared Solutions (Quest) Ltd. Miscellaneous Commercial ServicesCommercial Services Q Squared Solutions (Quest) Ltd. provides diagnostic services for high cholesterol, HIV, allergies, cancers, and other health conditions. The firm's laboratory in the UK serves both doctors and hospitals affiliated with the National Health Service as well as private practices and hospitals, other testing labs, corporations, government agencies, and prisons. The company was founded on April 14, 1999 and is headquartered in Hounslow, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
GENOMIC VISION | Medical Specialties | Chief Tech/Sci/R&D Officer | |
La Financière du Faouet SASU | Chairman | ||
Keranova SA
![]() Keranova SA Medical SpecialtiesHealth Technology Keranova SA designs and develops surgical equipment for various ophthalmologic indications that involve the anterior segment of the eye. The company was founded by Fabrizio Romano on September 4, 2015 and is headquartered in Saint-Etienne, France. | Medical Specialties | Director/Board Member | |
CELLECTIS S.A. | Pharmaceuticals: Major | Director of Finance/CFO | |
NG Biotech SAS
![]() NG Biotech SAS Medical SpecialtiesHealth Technology NG Biotech SAS is a French family-owned company founded in 2012 by a pioneer of the rapid test industry. The private company is based in Guipry-Messac, France. The company designs and manufactures innovative in vitro diagnostic tools suitable for decision making in medical emergencies, in the laboratory, and at the bedside. NG Biotech's innovation capabilities are powered by an expert R&D team backed by public-private scientific collaborations. The company proposes rapid tests in three main areas\: antimicrobial resistance, infectious disease (including COVID-19 tests), and women's health (blood pregnancy self-tests). NG Biotech's products are available in more than 70 countries, including the USA. The CEO is Milovan Stankov-Pugès. | Medical Specialties | Director/Board Member | |
Transcure Bioservices SAS
![]() Transcure Bioservices SAS Miscellaneous Commercial ServicesCommercial Services Transcure Bioservices SAS provides research and development platforms service. It offer services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling and development. The company was founded on June 07, 2012 and is headquartered in Archamps, France. | Miscellaneous Commercial Services | Director/Board Member | |
Clevexel Pharma SAS
![]() Clevexel Pharma SAS Pharmaceuticals: MajorHealth Technology Clevexel Pharma SAS manufactures as well as distributes pharmaceutical products. It engages in biotechnological research. The company was founded by Christian Bloy, Xiuping Wang-Zhang and Laurent Benel in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
Mexbrain SAS
![]() Mexbrain SAS Medical SpecialtiesHealth Technology Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation. | Medical Specialties | Director/Board Member | |
NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member | |
Financière Arbevel SA
![]() Financière Arbevel SA Investment ManagersFinance Financière Arbevel SA is an independent asset management firm headquartered in Paris, France. The firm was founded in 1997 and manages small and medium-sized French and European funds. Financière Arbevel is a socially responsible investor and signatory to the UN Principles for Responsible Investment (UNPRI) which integrates environmental, social, and governance considerations into their investment process. | Investment Managers | Portfolio Manager-Equities | |
France Biotech Association
![]() France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member | |
CYTOO SA
![]() CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member | |
Takara Bio Europe AB
![]() Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree | |
Escp Business School | College/University | Graduate Degree |
Statistiques
Internationale
France | 20 |
Royaume-Uni | 4 |
Etats-Unis | 3 |
Pays-Bas | 2 |
Sectorielle
Health Technology | 10 |
Commercial Services | 6 |
Finance | 5 |
Consumer Services | 5 |
Technology Services | 2 |
Opérationnelle
Director/Board Member | 14 |
Chairman | 3 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Founder | 2 |
Relations les plus connectées
Insiders | |
---|---|
Marc Le Bozec | 16 |
Arnaud Autret | 7 |
Pierre Walrafen | 5 |
- Bourse
- Insiders
- Stuart Edelstein
- Connexions Sociétés